Similar articles

• 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?

  Mayeno AN, Belongia EA, Lin F, Lundy SK, Gleich GJ. Mayeno AN, et al. Mayo Clin Proc. 1992 Dec;67(12):1134-9. doi: 10.1016/s0025-6196(12)61142-2. Mayo Clin Proc. 1992. PMID: 1469924
• L-tryptophan and the eosinophilia-myalgia syndrome.

  [No authors listed] [No authors listed] Drug Ther Bull. 1990 May 14;28(10):37-8. Drug Ther Bull. 1990. PMID: 2131206 Review. No abstract available.
• Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.

  Daniels SR, Hudson JI, Horwitz RI. Daniels SR, et al. J Clin Epidemiol. 1995 Dec;48(12):1413-27; discussion 1429-40. doi: 10.1016/0895-4356(95)00503-x. J Clin Epidemiol. 1995. PMID: 8543957 Review.
• The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.

  Hertzman PA. Hertzman PA. Adv Exp Med Biol. 1996;398:339-42. doi: 10.1007/978-1-4613-0381-7_52. Adv Exp Med Biol. 1996. PMID: 8906286 Review. No abstract available.
• Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome.

  Milburn DS, Myers CW. Milburn DS, et al. DICP. 1991 Nov;25(11):1259-62. doi: 10.1177/106002809102501116. DICP. 1991. PMID: 1763543 Review.